Therapeutic vaccines in HBV: lessons from HCV
Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to...
主要作者: | Barnes, E |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Springer Berlin Heidelberg
2015
|
相似書籍
-
HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
由: Yasmin Badshah, et al.
出版: (2025-01-01) -
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
由: Chih-Wei Tseng, et al.
出版: (2022-04-01) -
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
由: Almudena Torres-Cornejo, et al.
出版: (2017-04-01) -
HBV and HCV Therapy
由: Massimo Colombo, et al.
出版: (2009-10-01) -
Coinfección HBV-HCV y HIV-HCV
由: Fernando Bessone, et al.
出版: (2005-01-01)